Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported SUPN revenue for 2026-06-30 was $426.8M. Net income was -$60.7M. SUPN currently screens at market cap $2.53B.
Use this SUPN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SUPN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SUPN SEC filings page. Lician reads the product cache first so this HTML stays unique to Supernus Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full SUPN income, balance, and cash tables.